CONSOLIDATED STATEMENTS OF CASH FLOWS $ in Thousands	12 Months Ended
	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)
Cash Flows From Operating Activities
Net loss	$ (106,310)	$ (210,977)	$ (242,162)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	303,150	200,542	237,225
Bad debt expense	3,332	1,331	6,507
Deferred income tax benefit	(45,105)	357	(14,103)
Share-based compensation	35,422	51,383	13,715
Restructuring and impairment	5,288	0	0
Loss on extinguishment of debt	0	50,676	0
Gain on disposal of business	(29,192)	0	(39,104)
Impairment on assets held for sale	0	18,431	0
Deferred finance charges	5,752	2,496	9,182
Tax indemnity write-off	0	0	33,819
Other operating activities	2,611	(374)	(3,979)
Changes in operating assets and liabilities:
Accounts receivable	16,234	(593)	(50,906)
Prepaid expenses	5,245	(10,224)	(2,936)
Other assets	56,771	(975)	578
Accounts payable	(2,851)	(13,838)	(18,091)
Accrued expenses and other current liabilities	(90,568)	1,095	9,842
Deferred revenues	80,683	33,480	33,539
Operating lease right of use assets	5,329	11,365	0
Operating lease liabilities	(6,064)	(11,251)	0
Other liabilities	2,458	(5,344)	774
Net cash provided by operating activities	263,500	117,580	(26,100)
Cash Flows From Investing Activities
Capital expenditures	(107,713)	(69,836)	(45,410)
Acquisitions, net of cash acquired	(2,919,871)	(68,424)	(23,539)
Acquisition of intangible assets	(5,982)	(2,625)	0
Proceeds from sale of product line, net of restricted cash	41,398	0	80,883
Net cash used in investing activities	(2,992,168)	(140,885)	11,934
Cash Flows From Financing Activities
Proceeds from revolving credit facility	60,000	70,000	45,000
Principal payments on term loan	(12,600)	(641,509)	(46,709)
Repayments of revolving credit facility	(125,000)	(50,000)	(30,000)
Payment of debt issuance costs	(38,340)	(41,923)	0
Contingent purchase price payment	(7,816)	(2,371)	(2,470)
Proceeds from reverse recapitalization	0	682,087	0
Proceeds from issuance of debt	1,960,000	1,600,000	0
Extinguishment of debt	0	(1,342,651)	0
Tax receivable agreement payout	0	(200,000)	0
Proceeds from issuance of ordinary shares	843,744
Proceeds from warrant exercises	277,526	0	0
Proceeds from stock options exercised	2,122	1,582	1,574
Payments related to tax withholding for stock-based compensation	(33,056)	0	0
Net cash provided by (used in) financing activities	2,926,580	75,215	(32,605)
Effects of exchange rates	(5,043)	(971)	(5,193)
Net increase in cash and cash equivalents, and restricted cash	192,869	50,939	(51,964)
Cash:
Cash and cash equivalents	257,730	76,130	25,575
Restricted cash	11,278	9	9
Less: Cash included in assets held for sale, end of period	0	(384)	0
Total cash and cash equivalents, and restricted cash	269,008	76,139	25,584
Supplemental Cash Flow Information
Cash paid for interest	97,510	101,164	121,916
Cash paid for income tax	27,621	29,204	13,210
Capital expenditures included in accounts payable	7,783	8,762	5,166
Assets received as reverse recapitalization capital	0	1,877	0
Liabilities assumed as reduction of reverse recapitalization capital	0	5,910	0
Transaction & Prior Period Expense
Cost of revenues	(399,122)	(352,000)	(430,326)
Selling, general and administrative costs	(553,756)	$ (475,014)	$ (413,004)
Gain (Loss) on Foreign Currency Forward Contracts	(2,903)
Mark to Market Loss on Contingent Shares	$ 24,218